News Detail
Hyderabad, 31 Dec 2024: Drugs Control Administration, Telangana officials, detected certain medicines circulating in the market with misleading claims on their labels, stating that they treat, ‘Disorders of the menstrual flow’ ‘Rheumatism’, ‘Fev......
View Details
Source : DCA Telangana
Drugs Control Administration Telangana
misleading claims
Disorders of the menstrual flow
Rheumatism
Fevers
Pelvic Inflammatory Disease
For Prophylaxis and Treatment of Eye Infections
Drugs and Magic Remedies (Objectionable Advertisements) Act 1954
Retone Syrup
Vatari Churna
Vatari Churna
Soft Medicaps
Fourslab
Divya Pharmacy
OM Pharmaceuticals
Soft Medicaps Limited
Albert David Limited
Related News
- Health Ministry turns to other departments to fill CDSCO workforce gap (03-01-2025)
- Mankind Pharma and Innovent Biologics partner to commercialise Sintilimab (03-01-2025)
- FDA approves ALYFTREK™, once-daily triple-combination therapy for CF (03-01-2025)
- MIB drafts Rules for Online Ads, Influencer Marketing (03-01-2025)
- ICMR releases draft second edition of NEDL for stakeholders’ suggestions (03-01-2025)
- IIT Guwahati Researchers Develop Innovative Injectable Hydrogel for Targeted Breast Cancer Therapy (03-01-2025)
- CDSCO plans to up risk-based inspection, monitoring, sampling, enforcement to check spurious drugs (03-01-2025)
- Spurious life-saving drugs sourced from abroad for last 1.5 yrs (02-01-2025)
- Maha HM announces third-party testing of medicines supplied in state hospitals (02-01-2025)
- CDSCO brings clinical trial site addition and change of PI applications online (02-01-2025)